Sector revisions Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-02 EDT			5-day change	1st Jan Change
54.88 ^USD	+3.86%		+0.22%	+24.59%

06-11	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06-09	Scholar Rock Holding Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10:00 AM

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	SCHOLAR ROCK HOLDING CORPORATION							16
	ARGENX SE							15
	WUXI APPTEC CO., LTD.							16
	BIONTECH SE							20
	INSMED INCORPORATED							21
	WUXI BIOLOGICS (CAYMAN) INC.							22
	GENMAB A/S							15
	PHARMAESSENTIA CORPORATION							6
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	EXELIXIS, INC.							16
	MADRIGAL PHARMACEUTICALS, INC.							14
	AKESO, INC.							21
	SUMMIT THERAPEUTICS INC.							13
	ARROWHEAD PHARMACEUTICALS, INC.							12
	CYTOKINETICS, INCORPORATED							20
	REMEGEN CO., LTD.							14
	IMMUNITYBIO, INC.							3
	NUVALENT, INC.							16
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.							-
	VAXCYTE, INC.							9
	Average							15
	Weighted average by Cap.							16